English ticker view

RNA

ATRIUM THERAPEUTICS INC

This page combines public comments, SEC 13F holdings, insider trades, and simple return calculations for one ticker. Use the original source links before making your own decision.

Full Korean data view Search another ticker

Current price

$13.23

Public comments

13F holding rows

Insider trade rows

Public comments

Ranked by current return where prices are available.

13F direction

9 / 49

New or increased positions vs reduced or sold positions.

Insider activity

0 buyers

Based on SEC Form 4 market purchase and sale rows.

Latest comments

Most recent public records

No public comment records are connected to this ticker yet.

SEC 13F

Institution holding changes

Barclays PLC

decreased · May 15, 2026

-0.9%

Filing price $13.3504 · Current $13.23

Royal Bank of Canada

increased · May 15, 2026

-1.0%

Filing price $13.3647 · Current $13.23

UBS Asset Management Americas

decreased · May 13, 2026

-1.0%

Filing price $13.3693 · Current $13.23

Janus Henderson Group PLC

unchanged · May 18, 2026

-1.0%

Filing price $13.3695 · Current $13.23

Legal & General Group Plc

decreased · May 8, 2026

-1.0%

Filing price $13.3698 · Current $13.23

Citigroup Inc

decreased · May 11, 2026

-1.0%

Filing price $13.3699 · Current $13.23

New York State Common Retirement Fund

decreased · May 6, 2026

-1.0%

Filing price $13.37 · Current $13.23

Bank of New York Mellon Corp

decreased · May 5, 2026

-1.0%

Filing price $13.37 · Current $13.23

Insider trades

SEC Form 4 summary

No insider summary is connected to this ticker yet.

Information only. WhenBuy summarizes public data and simple calculations. It is not a stock recommendation, and returns may not reflect dividends, taxes, FX rates, fees, splits, or exact trade timing.